Chemotherapeutic management of advanced ovarian cancer.
OBJECTIVE
To review current treatment strategies for patients with advanced ovarian cancer. Factors for treatment selection are discussed.


METHODS
Research articles and textbooks.


CONCLUSIONS
Research efforts continue to identify novel agents and/or combination therapies that can effect a cure or prolong survival. Several agents offer similar efficacy outcomes but vary in safety aspects and administration requirements.


CONCLUSIONS
Numerous clinical trials have defined the efficacy and safety of chemotherapy in patients with ovarian cancer. Oncology nurses can prepare patients to make treatment decisions; educate them about treatment-related side effects; and develop an ongoing relationship as patient advocates to ensure quality of life.
Gordon
Alan N
AN
Departments of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Texas Tech University Health Sciences Center, Texas Oncology, PA, Dallas, TX, USA.
Butler
Julie
J
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D009859:Oncology Nursing; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000451:nursing; D011379:Prognosis; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index; D015996:Survival Rate
D000970:Antineoplastic Agents